Currently out of the existing stock ratings of Steven Breazzano, 4 are a HOLD (44.44%), 5 are a BUY (55.56%).

Steven Breazzano

Work Performance Price Targets & Ratings Chart

Analyst Steven Breazzano works with a stock forecast success ratio of 100% fulfilled within 178.5 days on average. Previously, Steven Breazzano worked at PIPER SANDLER.

Steven Breazzano’s has documented 19 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on RARE, Ultragenyx at 23-Mar-2017.

Wall Street Analyst Steven Breazzano

Analyst best performing recommendations are on RARE (ULTRAGENYX).
The best stock recommendation documented was for RARE (ULTRAGENYX) at 11/1/2016. The price target of $82 was fulfilled within 10 days with a profit of $21.78 (36.17%) receiving and performance score of 36.17.

Average potential price target upside

CLVS Clovis Oncology RARE Ultragenyx

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1 years 10 months 11 days ago

0/10 (0%)

$4.56 (102.70%)

Hold

4.75

$4.66 (5177.78%)

5.75

2 years 5 months 22 days ago

10/12 (83.33%)

$0.06 (1.28%)

65

Sell

3 years 5 months 19 days ago

3/5 (60%)

$5.73 (134.19%)

42

Buy

16

$15.91 (17677.78%)

17

3 years 8 months 18 days ago

5/12 (41.67%)

$10.58 (195.20%)

77

Sell

4

$3.91 (4344.44%)

3

3 years 11 months 19 days ago

3/5 (60%)

$-4.07 (-50.43%)

191

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Steven Breazzano?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?